Top Stories
-
The Ciccia laboratory has uncovered a novel vulnerability in certain breast and ovarian cancer cells, opening the door to new treatment options.
Topic
-
Congratulations to Dr. Melamed for being named to the new class of prestigious NAM Fellows.
Topic
-
In a new deep analysis of high-grade serous ovarian cancer (HGSOC), researchers have identified a common pathway that could provide a target for new drugs.
-
Dr. Alexander Melamed, a member of the Cancer Population Science program at the HICCC, joined Columbia in July of 2019 as assistant professor of obstetrics and gynecology at Columbia’s VP&S.
Topic
